{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:22:06Z","timestamp":1791195726091,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05319-z","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:10:11Z","timestamp":1761736211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Percentage of signal recovery (PSR): a more accurate marker than rCBV for differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiosurgery"],"prefix":"10.1007","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0248-1066","authenticated-orcid":false,"given":"Zhao Hui","family":"Chen Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Hilario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Salvador \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"C\u00e1rdenas del Carre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Lechuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mart\u00ednez de Arag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"D\u00b4Ambrosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"7","key":"5319_CR1","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1007\/s00330-025-11363-0","volume":"35","author":"ZH Chen Zhou","year":"2025","unstructured":"Chen Zhou ZH, Salvador \u00c1lvarez E, Hilario A, Del C\u00e1rdenas A, Romero Coronado J, Lechuga C, Mart\u00ednez de Arag\u00f3n A, Ramos Gonz\u00e1lez A (2025) Improved detection of brain metastases using contrast-enhanced 3D black-blood TSE sequences compared to post-contrast 3D T1 GRE: a comparative study on 1.5-T MRI. Eur Radiol 35(7):4267\u20134276. https:\/\/doi.org\/10.1007\/s00330-025-11363-0","journal-title":"Eur Radiol"},{"key":"5319_CR2","doi-asserted-by":"publisher","unstructured":"Chen Zhou ZH, D\u2032Ambrosi R, Hilario A, Salvador \u00c1lvarez E, C\u00e1rdenas del Carre A, Romero J, Lechuga C, Mart\u00ednez de Arag\u00f3n A, Ramos Gonz\u00e1lez A (2025) Improved target volume delineation for stereotactic radiosurgery in brain metastases using post-contrast 3D T1 TSE black blood MRI. Neuro-Oncology Advances https:\/\/doi.org\/10.1093\/noajnl\/vdaf207","DOI":"10.1093\/noajnl\/vdaf207"},{"issue":"11","key":"5319_CR3","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","volume":"32","author":"E Le Rhun","year":"2021","unstructured":"Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F, Galldiks N, de Azambuja E, Berghoff AS, Metellus P, Peters S, Hong YK, Winkler F, van den Schadendorf D, Seoane J, Stahel R, Minniti G, Wesseling P, Weller M, Preusser M (2021) EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann Oncol 32(11):1332\u20131347. https:\/\/doi.org\/10.1016\/j.annonc.2021.07.016","journal-title":"Ann Oncol"},{"issue":"10","key":"5319_CR4","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3174\/ajnr.A2668","volume":"32","author":"TR Patel","year":"2011","unstructured":"Patel TR, McHugh BJ, Bi WL, Minja FJ, Knisely JP, Chiang VL (2011) A comprehensive review of MR imaging changes following radiosurgery to 500 brain metastases. AJNR Am J Neuroradiol 32(10):1885\u20131892. https:\/\/doi.org\/10.3174\/ajnr.A2668","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"5319_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11060-012-0881-9","volume":"109","author":"AL Stockham","year":"2012","unstructured":"Stockham AL, Tievsky AL, Koyfman SA, Reddy CA, Suh JH, Vogelbaum MA, Barnett GH, Chao ST (2012) Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery. J Neurooncol 109(1):149\u2013158. https:\/\/doi.org\/10.1007\/s11060-012-0881-9","journal-title":"J Neurooncol"},{"issue":"9","key":"5319_CR6","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3174\/ajnr.A6153","volume":"40","author":"MD Lee","year":"2019","unstructured":"Lee MD, Baird GL, Bell LC, Quarles CC, Boxerman JL (2019) Utility of percentage signal recovery and baseline signal in DSC-MRI optimized for relative CBV measurement for differentiating Glioblastoma, Lymphoma, Metastasis, and meningioma. AJNR Am J Neuroradiol 40(9):1445\u20131450. https:\/\/doi.org\/10.3174\/ajnr.A6153","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"5319_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00234-023-03279-7","volume":"66","author":"A Hilario","year":"2024","unstructured":"Hilario A, Salvador E, Cardenas A, Romero J, Lechuga C, Chen Z, Martinez de Aragon A, Perez-Nu\u00f1ez A, Hernandez-Lain A, Sepulveda J, Lagares A, Toldos O, Rodriguez-Gonzalez V, Ramos A (2024) Low rCBV values in glioblastoma tumor progression under chemoradiotherapy. Neuroradiology 66(3):317\u2013323. https:\/\/doi.org\/10.1007\/s00234-023-03279-7","journal-title":"Neuroradiology"},{"key":"5319_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1696387","author":"G Quan","year":"2021","unstructured":"Quan G, Zhang K, Liu Y, Ren JL, Huang D, Wang W, Yuan T (2021) Role of dynamic susceptibility contrast perfusion MRI in glioma progression evaluation. J Oncol. https:\/\/doi.org\/10.1155\/2021\/1696387. 9;2021:1696387","journal-title":"J Oncol"},{"issue":"4","key":"5319_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.mric.2016.06.005","volume":"24","author":"JL Boxerman","year":"2016","unstructured":"Boxerman JL, Shiroishi MS, Ellingson BM, Pope WB (2016) Dynamic susceptibility contrast MR imaging in glioma: review of current clinical practice. Magn Reson Imaging Clin N Am 24(4):649\u2013670. https:\/\/doi.org\/10.1016\/j.mric.2016.06.005","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"1","key":"5319_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1148\/radiology.191.1.8134596","volume":"191","author":"HJ Aronen","year":"1994","unstructured":"Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191(1):41\u201351. https:\/\/doi.org\/10.1148\/radiology.191.1.8134596","journal-title":"Radiology"},{"issue":"1","key":"5319_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/jmri.1880070110","volume":"7","author":"R Brasch","year":"1997","unstructured":"Brasch R, Pham C, Shames D, Roberts T, van Dijke K, van Bruggen N, Mann J, Ostrowitzki S, Melnyk O (1997) Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 7(1):68\u201374. https:\/\/doi.org\/10.1002\/jmri.1880070110","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"5319_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11060-009-0106-z","volume":"99","author":"K Mitsuya","year":"2010","unstructured":"Mitsuya K, Nakasu Y, Horiguchi S, Harada H, Nishimura T, Bando E, Okawa H, Furukawa Y, Hirai T, Endo M (2010) Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neuroonco 99(1):81\u201388. https:\/\/doi.org\/10.1007\/s11060-009-0106-z","journal-title":"J Neuroonco"},{"issue":"2","key":"5319_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11060-019-03387-6","volume":"146","author":"Y Yang","year":"2020","unstructured":"Yang Y, Yang Y, Wu X, Pan Y, Zhou D, Zhang H, Chen Y, Zhao J, Mo Z, Huang B (2020) Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas. J Neurooncol 146(2):363\u2013371. https:\/\/doi.org\/10.1007\/s11060-019-03387-6","journal-title":"J Neurooncol"},{"issue":"5","key":"5319_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3174\/ajnr.A4218","volume":"36","author":"AJ Prager","year":"2015","unstructured":"Prager AJ, Martinez N, Beal K, Omuro A, Zhang Z, Young RJ (2015) Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence. AJNR Am J Neuroradiol 36(5):877\u2013885. https:\/\/doi.org\/10.3174\/ajnr.A4218","journal-title":"AJNR Am J Neuroradiol"},{"key":"5319_CR15","doi-asserted-by":"publisher","unstructured":"Hoefnagels FW, Lagerwaard FJ, Sanchez E, Haasbeek CJ, Knol DL, Slotman BJ, Vandertop WP (2009) Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol 256(6):878\u2009\u2013\u200987. https:\/\/doi.org\/10.1007\/s00415-009-5034-5","DOI":"10.1007\/s00415-009-5034-5"},{"issue":"5","key":"5319_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3174\/ajnr.A7501","volume":"43","author":"F Kuo","year":"2022","unstructured":"Kuo F, Ng NN, Nagpal S, Pollom EL, Soltys S, Hayden-Gephart M, Li G, Born DE, Iv M (2022) DSC perfusion MRI-Derived fractional tumor burden and relative CBV differentiate tumor progression and radiation necrosis in brain metastases treated with stereotactic radiosurgery. AJNR Am J Neuroradiol 43(5):689\u2013695. https:\/\/doi.org\/10.3174\/ajnr.A7501","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"5319_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/jmri.26812","volume":"51","author":"RM Kwee","year":"2020","unstructured":"Kwee RM, Kwee TC (2020) Dynamic susceptibility MR perfusion in diagnosing recurrent brain metastases after radiotherapy: A systematic review and meta-analysis. J Magn Reson Imaging 51(2):524\u2013534. https:\/\/doi.org\/10.1002\/jmri.26812","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"5319_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3174\/ajnr.A1362","volume":"30","author":"RF Barajas","year":"2009","unstructured":"Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, Cha S (2009) Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 30(2):367\u2013372. https:\/\/doi.org\/10.3174\/ajnr.A1362","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"5319_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1148\/radiol.2492071659","volume":"249","author":"ES Paulson","year":"2008","unstructured":"Paulson ES, Schmainda KM (2008) Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 249(2):601\u2013613. https:\/\/doi.org\/10.1148\/radiol.2492071659","journal-title":"Radiology"},{"issue":"2","key":"5319_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11060-019-03244-6","volume":"144","author":"E Steidl","year":"2019","unstructured":"Steidl E, M\u00fcller M, M\u00fcller A, Herrlinger U, Hattingen E (2019) Longitudinal, leakage corrected and uncorrected rCBV during the first-line treatment of glioblastoma: a prospective study. J Neurooncol 144(2):409\u2013417. https:\/\/doi.org\/10.1007\/s11060-019-03244-6","journal-title":"J Neurooncol"},{"key":"5319_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejca.2019.03.007","volume":"114","author":"M Smits","year":"2019","unstructured":"Smits M, Bendszus M, Collette S, Postma LA, Dhermain F, Hagenbeek RE, Clement PM, Liu Y, van den Wick W, Heiland S (2019) Repeatability and reproducibility of relative cerebral blood volume measurement of recurrent glioma in a multicentre trial setting. Eur J Cancer 114:89\u201396. https:\/\/doi.org\/10.1016\/j.ejca.2019.03.007","journal-title":"Eur J Cancer"},{"issue":"9","key":"5319_CR22","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1007\/s00330-018-5353-y","volume":"28","author":"MTH Oei","year":"2018","unstructured":"Oei MTH, Meijer FJA, Mordang JJ, Smit EJ, Idema AJS, Goraj BM, Laue HOA, Prokop M, Manniesing R (2018) Observer variability of reference tissue selection for relativecerebral blood volume measurements in glioma patients. Eur Radiol 28(9):3902\u20133911. https:\/\/doi.org\/10.1007\/s00330-018-5353-y","journal-title":"Eur Radiol"},{"issue":"4","key":"5319_CR23","first-page":"859","volume":"27","author":"JL Boxerman","year":"2006","unstructured":"Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27(4):859\u2013867","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"5319_CR24","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3174\/ajnr.A0484","volume":"28","author":"S Cha","year":"2007","unstructured":"Cha S, Lupo JM, Chen MH, Lamborn KR, McDermott MW, Berger MS, Nelson SJ, Dillon WP (2007) Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 28(6):1078\u20131084. https:\/\/doi.org\/10.3174\/ajnr.A0484","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"5319_CR25","doi-asserted-by":"publisher","first-page":"e0141438","DOI":"10.1371\/journal.pone.0141438","volume":"7","author":"MT Chuang","year":"2016","unstructured":"Chuang MT, Liu YS, Tsai YS, Chen YC, Wang CK (2016) Differentiating Radiation-Induced necrosis from recurrent brain tumor using MR perfusion and spectroscopy: A Meta-Analysis. PLoS ONE 7(1):e0141438. https:\/\/doi.org\/10.1371\/journal.pone.0141438","journal-title":"PLoS ONE"},{"key":"5319_CR26","doi-asserted-by":"publisher","unstructured":"Kleinschmidt-DeMasters BK, Lillehei KO (2016) Radiation-induced cerebral vascular malformations at biopsy. J Neuropathol Exp Neurol 1 75(11):1081\u20131092. https:\/\/doi.org\/10.1093\/jnen\/nlw085","DOI":"10.1093\/jnen\/nlw085"},{"issue":"7","key":"5319_CR27","doi-asserted-by":"publisher","first-page":"107699","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107699","volume":"33","author":"RJ Alcazar-Felix","year":"2024","unstructured":"Alcazar-Felix RJ, Srinath A, Hage S, Bindal A, Ressler A, Pytel P, Allaw S, Girard R, Marchuk DA, Awad IA, Polster SP (2024) Pathologic features of brain hemorrhage after radiation treatment: case series with somatic mutation analysis. J Stroke Cerebrovasc Dis 33(7):107699. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2024.107699","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"5319_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3174\/ajnr.A2441","volume":"32","author":"R Mangla","year":"2011","unstructured":"Mangla R, Kolar B, Zhu T, Zhong J, Almast J, Ekholm S (2011) Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 32(6):1004\u20131010. https:\/\/doi.org\/10.3174\/ajnr.A2441","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"5319_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.18383\/j.tom.2017.00004","volume":"3","author":"LC Bell","year":"2017","unstructured":"Bell LC, Hu LS, Stokes AM, McGee SC, Baxter LC, Quarles CC (2017) Characterizing the influence of preload dosing on percent signal recovery (PSR) and cerebral blood volume (CBV) measurements in a patient population with High-Grade glioma using dynamic susceptibility contrast MRI. Tomography 3(2):89\u201395. https:\/\/doi.org\/10.18383\/j.tom.2017.00004","journal-title":"Tomography"},{"issue":"10","key":"5319_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00234-006-0115-y","volume":"48","author":"B Hakyemez","year":"2006","unstructured":"Hakyemez B, Yildirim N, Erdo\u011fan C, Kocaeli H, Korfali E, Parlak M (2006) Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation? Neuroradiology 48(10):695\u2013702. https:\/\/doi.org\/10.1007\/s00234-006-0115-y","journal-title":"Neuroradiology"},{"issue":"7","key":"5319_CR31","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3174\/ajnr.A3477","volume":"34","author":"JL Boxerman","year":"2013","unstructured":"Boxerman JL, Paulson ES, Prah MA, Schmainda KM (2013) The effect of pulse sequence parameters and contrast agent dose on percentage signal recovery in DSC-MRI: implications for clinical applications. AJNR Am J Neuroradiol 34(7):1364\u20131369. https:\/\/doi.org\/10.3174\/ajnr.A3477","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"5319_CR32","first-page":"1915","volume":"22","author":"H Uematsu","year":"2001","unstructured":"Uematsu H, Maeda M, Sadato N, Matsuda T, Ishimori Y, Koshimoto Y, Kimura H, Yamada H, Kawamura Y, Yonekura Y, Itoh H (2001) Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. AJNR Am J Neuroradiol 22(10):1915\u20131919","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"5319_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3174\/ajnr.A5027","volume":"38","author":"K Leu","year":"2017","unstructured":"Leu K, Boxerman JL, Ellingson BM (2017) Effects of MRI protocol Parameters, preload injection Dose, fractionation Strategies, and leakage correction algorithms on the fidelity of Dynamic-Susceptibility contrast MRI estimates of relative cerebral blood volume in gliomas. AJNR Am J Neuroradiol 38(3):478\u2013484. https:\/\/doi.org\/10.3174\/ajnr.A5027","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"5319_CR34","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/mrm.30383","volume":"93","author":"D van Dorth","year":"2025","unstructured":"van Dorth D, van der Venugopal K, Smits M, Warnert EAH, Hernandez-Tamames JA, van Osch MJP, Poot DHJ (2025) Exploring the need for a preload on the Estimation of permeability, vessel radius, and relative cerebral blood volume in MR vascular fingerprinting-based dynamic susceptibility contrast perfusion imaging. Magn Reson Med 93(4):1761\u20131770. https:\/\/doi.org\/10.1002\/mrm.30383","journal-title":"Magn Reson Med"},{"key":"5319_CR35","doi-asserted-by":"publisher","unstructured":"Boxerman JL, Prah DE, Paulson ES, Machan JT, Bedekar D, Schmainda KM (2012) The Role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard. AJNR Am J Neuroradiol 33(6):1081-7. https:\/\/doi.org\/10.3174\/ajnr.A2934","DOI":"10.3174\/ajnr.A2934"},{"issue":"12","key":"5319_CR36","doi-asserted-by":"publisher","first-page":"8800","DOI":"10.1007\/s00330-023-09917-1","volume":"33","author":"F Wang","year":"2023","unstructured":"Wang F, Zhou X, Chen R, Kang J, Yang X, Lin J, Liu F, Cao D, Xing Z (2023) Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma. Eur Radiol 33(12):8800\u20138808. https:\/\/doi.org\/10.1007\/s00330-023-09917-1","journal-title":"Eur Radiol"},{"issue":"3","key":"5319_CR37","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/mrm.25435","volume":"74","author":"NB Semmineh","year":"2015","unstructured":"Semmineh NB, Xu J, Skinner JT, Xie J, Li H, Ayers G, Quarles CC (2015) Assessing tumor cytoarchitecture using Multiecho DSC-MRI derived measures of the transverse relaxivity at tracer equilibrium (TRATE). Magn Reson Med 74(3):772\u2013784. https:\/\/doi.org\/10.1002\/mrm.25435","journal-title":"Magn Reson Med"},{"key":"5319_CR38","doi-asserted-by":"publisher","unstructured":"Kamiryo T, Lopes MB, Kassell NF, Steiner L, Lee KS (2001) Radiosurgery-induced microvascular alterations precede necrosis of the brain neuropil. Neurosurgery 49(2):409\u201314;414-5. https:\/\/doi.org\/10.1097\/00006123-200108000-00026","DOI":"10.1097\/00006123-200108000-00026"},{"issue":"2","key":"5319_CR39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3174\/ajnr.A5472","volume":"39","author":"H Li","year":"2018","unstructured":"Li H, Deng L, Bai HX, Sun J, Cao Y, Tao Y, States LJ, Farwell MD, Zhang P, Xiao B, Yang L (2018) Diagnostic accuracy of amino acid and FDG-PET in differentiating brain metastasis recurrence from radionecrosis after radiotherapy: A systematic review and Meta-Analysis. AJNR Am J Neuroradiol 39(2):280\u2013288. https:\/\/doi.org\/10.3174\/ajnr.A5472","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"5319_CR40","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11060-023-04377-5","volume":"163","author":"MC Tom","year":"2023","unstructured":"Tom MC, DiFilippo FP, Jones SE, Suh JH, Obuchowski NA, Smile TD, Murphy ES, Yu JS, Barnett GH, Angelov L, Mohammadi AM, Huang SS, Wu G, Johnson S, Peereboom DM, Stevens GHJ, Ahluwalia MS, Chao ST (2023) 18F-fluciclovine PET\/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study. J Neurooncol 163(3):647\u2013655. https:\/\/doi.org\/10.1007\/s11060-023-04377-5","journal-title":"J Neurooncol"},{"issue":"5","key":"5319_CR41","doi-asserted-by":"publisher","first-page":"816","DOI":"10.2967\/jnumed.122.264803","volume":"64","author":"T Schl\u00fcrmann","year":"2022","unstructured":"Schl\u00fcrmann T, Waschulzik B, Combs S, Gempt J, Wiestler B, Weber W, Yakushev I (2022) Utility of amino acid PET in the differential diagnosis of recurrent brain metastases and Treatment-Related changes: A Meta-analysis. J Nucl Med 64(5):816\u2013821. https:\/\/doi.org\/10.2967\/jnumed.122.264803","journal-title":"J Nucl Med"},{"issue":"1","key":"5319_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/197140091202500109","volume":"25","author":"H Zhang","year":"2012","unstructured":"Zhang H, Zhang G, Oudkerk M (2012) Brain metastases from different primary carcinomas: an evaluation of DSC MRI measurements. Neuroradiol J 25(1):67\u201375. https:\/\/doi.org\/10.1177\/197140091202500109","journal-title":"Neuroradiol J"},{"key":"5319_CR43","doi-asserted-by":"publisher","first-page":"823731","DOI":"10.3389\/fneur.2022.823731","volume":"18","author":"Y Yunqi","year":"2022","unstructured":"Yunqi Y, Aihua N, Zhiming Z, Yingchao L, Qiang W, Yang M, Yi Z (2022) Quantitative MR perfusion for the differentiation of recurrence and radionecrosis in hypoperfusion and hyperperfusion brain metastases after gamma knife radiosurgery. Front Neurol 18:13:823731. https:\/\/doi.org\/10.3389\/fneur.2022.823731","journal-title":"Front Neurol"},{"issue":"2","key":"5319_CR44","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1006\/jmre.1997.1317","volume":"130","author":"JM Levin","year":"1998","unstructured":"Levin JM, Wald LL, Kaufman MJ, Ross MH, Maas LC, Renshaw PF (1998) T1 effects in sequential dynamic susceptibility contrast experiments. J Magn Reson 130(2):292\u2013295. https:\/\/doi.org\/10.1006\/jmre.1997.1317","journal-title":"J Magn Reson"},{"issue":"6","key":"5319_CR45","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.3174\/ajnr.A4341","volume":"36","author":"K Welker","year":"2015","unstructured":"Welker K, Boxerman J, Kalnin A, Kaufmann T, Shiroishi M, Wintermark M, American Society of Functional Neuroradiology MR Perfusion Standards and Practice Subcommittee of the ASFNR Clinical Practice Committee (2015) ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR Am J Neuroradiol 36(6):E41\u201351. https:\/\/doi.org\/10.3174\/ajnr.A4341","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05319-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05319-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05319-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:34:39Z","timestamp":1767702879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05319-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5319"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05319-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of local committee of the hospital and it was in accordance with the 1964 Helsinki Declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patient consent was waived due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}